FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2097457805> ?p ?o ?g. }

• W2097457805 endingPage "178" @default.
• W2097457805 startingPage "172" @default.
• W2097457805 abstract "To examine the effect of rosiglitazone on insulin resistance and blood pressure in patients with essential hypertension, classified based on abnormalities of their renin-angiotensin system.A total of 24 hypertensive nondiabetic patients (age 58 +/- 6 years, BMI 30 +/- 5 kg/m2) were studied before and after rosiglitazone treatment. After 2 weeks off antihypertensive medication, subjects received a euglycemic-hyperinsulinemic clamp (40 mU. m(-2). min(-1)) with 6,6-[2H2]glucose infusion, ambulatory blood pressure monitoring, and blood tests for cardiovascular risk factors. Subjects were then placed on rosiglitazone (4 mg orally b.i.d.) and their usual antihypertensive medications (but not ACE inhibitors) for 16 weeks, and baseline tests were repeated.There was no change in fasting plasma glucose (83 +/- 2 vs. 82 +/- 2 mg/dl, P = 0.60), but fasting insulin decreased (16.1 +/- 1.4 vs. 12.5 +/- 0.9 micro U/ml, P < 0.01). Total glucose disposal during the clamp increased (5.0 +/- 0.4 vs. 5.9 +/- 0.5 mg. kg(-1). min(-1), P < 0.001), with no change in suppression of hepatic glucose output. There were significant decreases in mean 24-h systolic (138 +/- 2 vs. 134 +/- 2 mmHg, P < 0.02) and diastolic (85 +/- 2 vs. 80 +/- 2 mmHg, P < 0.0001) blood pressure, and the decline in systolic blood pressure was correlated with the improvement in insulin sensitivity (r = 0.59, P < 0.005). Triglycerides (135 +/- 16 vs. 89 +/- 8 mg/dl, P < 0.01), LDL cholesterol (129 +/- 6 vs. 122 +/- 8 mg/dl, P = 0.18), and HDL cholesterol (51 +/- 3 vs. 46 +/- 3 mg/dl, P < 0.02) all decreased, with no change in the LDL-to-HDL ratio. Plasminogen activator inhibitor-1 and C-reactive protein also declined significantly.Rosiglitazone treatment of nondiabetic hypertensive patients improves insulin sensitivity, reduces systolic and diastolic blood pressure, and induces favorable changes in markers of cardiovascular risk. Insulin sensitizers may provide cardiovascular benefits when used in the treatment of patients with hypertension." @default.
• W2097457805 created "2016-06-24" @default.
• W2097457805 creator A5030601213 @default.
• W2097457805 creator A5038247520 @default.
• W2097457805 creator A5047140893 @default.
• W2097457805 creator A5062891170 @default.
• W2097457805 creator A5083651022 @default.
• W2097457805 date "2003-01-01" @default.
• W2097457805 modified "2023-10-13" @default.
• W2097457805 title "Rosiglitazone Improves Insulin Sensitivity and Lowers Blood Pressure in Hypertensive Patients" @default.
• W2097457805 cites W1604542334 @default.
• W2097457805 cites W175652702 @default.
• W2097457805 cites W1955615888 @default.
• W2097457805 cites W1963886325 @default.
• W2097457805 cites W1970930655 @default.
• W2097457805 cites W1974509672 @default.
• W2097457805 cites W1976347558 @default.
• W2097457805 cites W1985709687 @default.
• W2097457805 cites W1987354753 @default.
• W2097457805 cites W1998619326 @default.
• W2097457805 cites W2010428766 @default.
• W2097457805 cites W2014877159 @default.
• W2097457805 cites W2016965640 @default.
• W2097457805 cites W2030973204 @default.
• W2097457805 cites W2031032207 @default.
• W2097457805 cites W2044548466 @default.
• W2097457805 cites W2048529677 @default.
• W2097457805 cites W2051235217 @default.
• W2097457805 cites W2052122922 @default.
• W2097457805 cites W2054205498 @default.
• W2097457805 cites W2059354372 @default.
• W2097457805 cites W2060544145 @default.
• W2097457805 cites W2073807083 @default.
• W2097457805 cites W2084038315 @default.
• W2097457805 cites W2094394439 @default.
• W2097457805 cites W2094595851 @default.
• W2097457805 cites W2096773810 @default.
• W2097457805 cites W2103844937 @default.
• W2097457805 cites W2105912552 @default.
• W2097457805 cites W2111279044 @default.
• W2097457805 cites W2114510502 @default.
• W2097457805 cites W2119316150 @default.
• W2097457805 cites W2128712342 @default.
• W2097457805 cites W2134139026 @default.
• W2097457805 cites W2134261100 @default.
• W2097457805 cites W2146557873 @default.
• W2097457805 cites W2151522859 @default.
• W2097457805 cites W2168588540 @default.
• W2097457805 cites W2318286274 @default.
• W2097457805 cites W2319850088 @default.
• W2097457805 cites W2320006945 @default.
• W2097457805 cites W2330478256 @default.
• W2097457805 cites W2337133379 @default.
• W2097457805 cites W4245696520 @default.
• W2097457805 cites W4253688138 @default.
• W2097457805 doi "https://doi.org/10.2337/diacare.26.1.172" @default.
• W2097457805 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12502676" @default.
• W2097457805 hasPublicationYear "2003" @default.
• W2097457805 type Work @default.
• W2097457805 sameAs 2097457805 @default.
• W2097457805 citedByCount "207" @default.
• W2097457805 countsByYear W20974578052012 @default.
• W2097457805 countsByYear W20974578052013 @default.
• W2097457805 countsByYear W20974578052014 @default.
• W2097457805 countsByYear W20974578052015 @default.
• W2097457805 countsByYear W20974578052016 @default.
• W2097457805 countsByYear W20974578052017 @default.
• W2097457805 countsByYear W20974578052018 @default.
• W2097457805 countsByYear W20974578052019 @default.
• W2097457805 countsByYear W20974578052020 @default.
• W2097457805 countsByYear W20974578052021 @default.
• W2097457805 countsByYear W20974578052022 @default.
• W2097457805 countsByYear W20974578052023 @default.
• W2097457805 crossrefType "journal-article" @default.
• W2097457805 hasAuthorship W2097457805A5030601213 @default.
• W2097457805 hasAuthorship W2097457805A5038247520 @default.
• W2097457805 hasAuthorship W2097457805A5047140893 @default.
• W2097457805 hasAuthorship W2097457805A5062891170 @default.
• W2097457805 hasAuthorship W2097457805A5083651022 @default.
• W2097457805 hasBestOaLocation W20974578051 @default.
• W2097457805 hasConcept C126322002 @default.
• W2097457805 hasConcept C134018914 @default.
• W2097457805 hasConcept C149323552 @default.
• W2097457805 hasConcept C2777391703 @default.
• W2097457805 hasConcept C2779306644 @default.
• W2097457805 hasConcept C2780152017 @default.
• W2097457805 hasConcept C35785553 @default.
• W2097457805 hasConcept C555293320 @default.
• W2097457805 hasConcept C71924100 @default.
• W2097457805 hasConcept C84393581 @default.
• W2097457805 hasConceptScore W2097457805C126322002 @default.
• W2097457805 hasConceptScore W2097457805C134018914 @default.
• W2097457805 hasConceptScore W2097457805C149323552 @default.
• W2097457805 hasConceptScore W2097457805C2777391703 @default.
• W2097457805 hasConceptScore W2097457805C2779306644 @default.
• W2097457805 hasConceptScore W2097457805C2780152017 @default.
• W2097457805 hasConceptScore W2097457805C35785553 @default.
• W2097457805 hasConceptScore W2097457805C555293320 @default.

• next